COMMUNIQUÉS West-GlobeNewswire

Momenta Pharmaceuticals to Webcast Presentation at the Goldman Sachs 39th Annual Global Healthcare Conference
06/06/2018
CAMBRIDGE, Mass., June 06, 2018 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA), today announced that it will present at the Goldman Sachs 39th Annual Global Healthcare Conference. The presentation is [...]
Lundbeck reaches voluntary agreement in principle with U.S. Department of Justice
06/06/2018
Valby, Denmark, 6 June 2018 - H. Lundbeck A/S (Lundbeck) today announced that its U.S. subsidiary Lundbeck LLC has reached an agreement in principle to resolve the U.S. Department of Justice (DOJ) investigation related [...]
National Brain Tumor Society-Championed Childhood Cancer STAR Act Signed Into Law
06/06/2018
Boston, MA, June 06, 2018 (GLOBE NEWSWIRE) -- Today, the Childhood Cancer STAR (Survivorship, Treatment, Access and Research) Act was signed into law. This pivotal moment marks a major victory for brain tumor and [...]
GW Pharmaceuticals to Present at the Goldman Sachs 39th Annual Global Healthcare Conference
06/06/2018
LONDON and CARLSBAD, Calif., June 06, 2018 (GLOBE NEWSWIRE) -- GW Pharmaceuticals plc (NASDAQ:GWPH) (GW, the Company or the Group), a biopharmaceutical company focused on discovering, developing and commercializing [...]
Nohla Receives EMA PRIME Designation for Dilanubicel (NLA101) to Treat Hematopoietic Stem Cell Transplant Patients
06/06/2018
First Product to Achieve PRIME Designation for Hematopoietic Stem Cell Transplant Patients SEATTLE, June 06, 2018 (GLOBE NEWSWIRE) -- Nohla Therapeutics, a leading developer of universal, off-the-shelf cell therapies [...]
Nova Scotia Exports Mental Health Resources
06/06/2018
HALIFAX, Nova Scotia, June 06, 2018 (GLOBE NEWSWIRE) -- Two evidence-based mental health resources originally developed in Nova Scotia, are launching in schools and universities across the United Kingdom today. [...]
Essilor: Disclosure of Share Capital and Voting Rights Outstanding as of May 31, 2018
06/06/2018
Disclosure of Share Capital and Voting Rights Outstanding as of May 31, 2018 (Pursuant to Article L.233-8 II of the French Commercial Code and articles 221-1 and 223-16 of the General Regulations of the Autorité des [...]
Essilor : Nombre total de droits de vote et d'actions composant le capital social au 31 mai 2018
06/06/2018
Nombre total de droits de vote et d'actions composant le capital social au 31 mai 2018 (Article L.233-8 II du Code de Commerce et les articles 221-1 et 223-16 du Règlement Général de l'AMF) Charenton-le-Pont, France (le [...]
VALNEVA : Déclaration d'actions et de droits de vote - MAI 2018
06/06/2018
VALNEVA Déclaration d'actions et de droits de vote - MAI 2018 Dénomination sociale : VALNEVA Adresse du siège social : World Trade Center Lyon - Tour Oxygène, 10-12 Boulevard Marius Vivier Merle, 69003 Lyon Marché [...]
Michael Feltes, MD is Appointed to the American Health Council’s Board of Physicians
06/06/2018
NEW YORK, June 06, 2018 (GLOBE NEWSWIRE) -- The American Health Council has appointed Michael Feltes, MD to its Board of Physicians for his outstanding contributions to the medical field. Dr. Feltes is the founder of [...]
NANOBIOTIX' Management statement on recent share price variation
06/06/2018
NANOBIOTIX' MANAGEMENT STATEMENT ON RECENT SHARE PRICE VARIATION Paris, France and Cambridge, Massachusetts, USA, June 6 2018 - NANOBIOTIX (Euronext: NANO - ISIN: FR0011341205), a late clinical-stage nanomedicine [...]
NANOBIOTIX : Déclaration à la suite de la variation récente du prix de l'action
06/06/2018
NANOBIOTIX : DECLARATION A LA SUITE DE LA VARIATION RECENTE DU PRIX DE L'ACTION Paris, France et Cambridge, Massachusetts, USA, 6 juin 2018 - NANOBIOTIX (Euronext: NANO - ISIN: FR0011341205), société française pionnière [...]
CohBar to Hold 2018 Annual Shareholder Meeting and Investor Update, June 19, 2018
06/06/2018
MENLO PARK, Calif., June 06, 2018 (GLOBE NEWSWIRE) -- CohBar, Inc. (NASDAQ:CWBR) (“CohBar” or the “Company”), an innovative biotechnology company developing mitochondria based therapeutics (MBTs) to treat age-related [...]
Moleculin’s Breakthrough Discovery of a New Molecule for Cancer Treatment Advances to Development Agreement with the University of Iowa
06/06/2018
HOUSTON, June 06, 2018 (GLOBE NEWSWIRE) -- Moleculin Biotech, Inc., (Nasdaq:MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company focused on the development of oncology drug candidates, all of [...]
FlexDex, Inc. Appoints New Vice President, Research and Development and Vice President, International Sales and Marketing
06/06/2018
BRIGHTON, Mich., June 06, 2018 (GLOBE NEWSWIRE) -- FlexDex, Inc. (“FlexDex” or “Company”), a medical device company that is developing a platform of articulating laparoscopic instruments for minimally invasive surgery, [...]
FDA Letter to Health Care Providers Related to Potential Risks, Including Death, with Liquid-Filled Intragastric Balloons for Weight Loss NOT Related to The Obalon Gas-Filled Balloon
06/06/2018
No Reports of Deaths Related to Use of Obalon Six-Month Balloon System SAN DIEGO, June 06, 2018 (GLOBE NEWSWIRE) -- Obalon Therapeutics, Inc. (“Obalon” or the “Company”) (NASDAQ:OBLN), a vertically integrated medical [...]
CEO Ronan O’Caoimh Increases Shareholding in Trinity Biotech
06/06/2018
DUBLIN, Ireland, June 06, 2018 (GLOBE NEWSWIRE) -- Trinity Biotech plc (Nasdaq:TRIB), today announced that Ronan O’Caoimh, CEO of Trinity Biotech, has increased his shareholding in Trinity Biotech by the acquisition of [...]
Abeona Therapeutics Announces Upcoming Presentation at Jefferies 2018 Global Healthcare Conference
06/06/2018
Company CEO to Present on Thursday, June 7th at 11:00 AM ET NEW YORK and CLEVELAND, June 06, 2018 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (NASDAQ:ABEO), a leading clinical-stage biopharmaceutical company focused on [...]
Navamedic ASA: Share option program
06/06/2018
On the basis of the approval by the Annual General Meeting of June 6 th 2017, to authorize the Board to issue 150 000 new shares to management under a long-term incentive program, the Board has now resolved to issue [...]

Pages